P022 Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans
Am J Gastroenterol
.
2020 Dec 1;115(Suppl 1):S6.
doi: 10.14309/01.ajg.0000722884.49445.dd.
Authors
Pinnell Derek
1
,
Johnson Jessica
1
,
Sauer Brian
1
,
Pei Shoabo
1
,
Chen Wei
1
,
Rojas Jorge
1
,
Gawron Andrew
2
,
Baker Joshua
3
,
Curtis Jeffrey
4
,
Star Vicki
5
,
Wu David
5
,
Walsh Jessica
1
Affiliations
1
University of Utah/VA Salt Lake City Healthcare System, Salt Lake City, United States.
2
University of Utah School of Medicine, Salt Lake City1, United States.
3
Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
4
University of Alabama, Tuscaloosa, United States.
5
Merck & Co., Inc., Kenilworth, United States.
PMID:
33566496
DOI:
10.14309/01.ajg.0000722884.49445.dd
No abstract available